CDC Advisory Panel’s Hepatitis B Vaccine Schedule Change Sparks Debate
The hepatitis B vaccine schedule for newborns has recently been altered by a CDC advisory panel, garnering substantial debate. This change, endorsed by President Trump and Secretary RFK Jr., aims to modify the existing guidance. Critics argue that it risks reversing the progress made in reducing hepatitis B infections among newborns. The newly proposed schedule has ignited discussions within public health circles and raised concerns about the broader implications for healthcare policies in Australia.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article ā